Douglas Roblin to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Douglas Roblin has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
0.093
-
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007 Jan; 16(1):55-64.
Score: 0.073
-
Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf. 2008 Mar; 17(3):240-7.
Score: 0.020